Low-dose metronomic eribulin in metastatic breast cancer: Is this real metronomic therapy?

被引：0
|
作者：
Altundag, Kadri [1 ]
机构：
[1] MKA Breast Canc Clin, Ankara, Turkey
来源：
JOURNAL OF BUON | 2021年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1174 / 1174
页数：1
相关论文
共 50 条
  • [31] Low-Dose Metronomic Paclitaxel Chemotherapy Suppresses Breast Tumors and Metastases in Mice
    Jiang, Hongchi
    Tao, Weiyang
    Zhang, Mu
    Pan, Shangha
    Kanwar, Jagat R.
    Sun, Xueying
    CANCER INVESTIGATION, 2010, 28 (01) : 74 - 84
  • [32] Optimal low-dose metronomic chemotherapy and antiangiogenic activity
    Ruth Kirby
    Nature Clinical Practice Oncology, 2005, 2 (10): : 489 - 489
  • [33] Low-dose metronomic chemotherapy: A systematic literature analysis
    Lien, K.
    Georgsdottir, S.
    Sivanathan, L.
    Chan, K.
    Emmenegger, U.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (16) : 3387 - 3395
  • [34] Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in mice
    Emmenegger, Urban
    Shaked, Yuval
    Man, Shan
    Bocci, Guido
    Spasojevic, Ivan
    Francia, Giulio
    Kouri, Andrew
    Coke, Robert
    Cruz-Munoz, William
    Ludeman, Susan M.
    Colvin, O. Michael
    Kerbel, Robert S.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (08) : 2280 - 2289
  • [35] Safety and efficacy of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
    Kudo, Shun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] ANTI-TUMOR EFFECTS OF LOW-DOSE METRONOMIC VINORELBINE IN COMBINATION WITH ALPELISIB IN BREAST CANCER CELLS
    Krajnak, Slavomir
    Trier, Jannis Patrik
    Heinzmann, Pauline Friederike
    Anic, Katharina
    Heimes, Anne-Sophie
    Loewe, Amelie
    Schmidt, Marcus
    Johannes, Marco
    Hasenburg, Annette
    Brenner, Walburgis
    EXCLI JOURNAL, 2022, 22 : 114 - 130
  • [37] Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer-results of an exploratory case-control study
    Krajnak, S.
    Schnatz, C.
    Almstedt, K.
    Brenner, W.
    Haertner, F.
    Heimes, A-S
    Lebrecht, A.
    Makris, G-M
    Schwab, R.
    Hasenburg, A.
    Schmidt, M.
    Battista, M. J.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (02) : 389 - 399
  • [38] Metronomic chemotherapy in metastatic breast cancer: Impact on VEGF
    El-Arab, Lobna R. Ezz
    Swellam, Menha
    El Mahdy, Manal M.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2012, 24 (01) : 15 - 22
  • [39] Metronomic chemotherapy for metastatic breast cancer: a case study
    Gaumier, A.
    Hamizi, S.
    You, B.
    Freyer, G.
    ONCOLOGIE, 2010, 12 (07) : 436 - 439
  • [40] Low-Dose Immunotherapy Plus Triple Metronomic Chemotherapy for Head and Neck Cancer
    Mo, Dun-Chang
    Huang, Jian-Feng
    Luo, Peng-Hui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (09) : 1790 - +
12345